Prospects for CV Risk Factor Reduction with PCSK9 and CEPT Inhibitor Therapies - A. Michael Lincoff, MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Prospects for CV Risk Factor Reduction with PCSK9 and CEPT Inhibitor Therapies presented by A. Michael Lincoff, MD at CRT 2016

Loading Simple Education